The Next Generation Cannabis Platform

Made public by

Jushi

sourced by PitchSend

4 of 30

Creator

Jushi

Category

Healthcare

Published

2024

Slides

Transcriptions

#1www. & THE THE Jushi The Next Generation Cannabis Platform TIPS G#2Cautionary Statement Regarding Forward-Looking Statements This presentation contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation as well as statements that may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our strategy, future operations, intended expansion of our retail operations and production capacity, intended expansion of our cultivation facilities, future financial position, projected costs, prospects, plans and objectives of management, are forward-looking statements. These forward-looking statements are based on Jushi's current expectations and beliefs concerning future developments and their potential effects. As a result, actual results could differ materially from those expressed by such forward-looking statements and such statements should not be relied upon. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans," "expects" or "does not expect," "is expected," "budget," "scheduled," "estimates," "forecasts," "intends," "anticipates" or "does not anticipate," or "believes," or variations of such words and phrases or may contain statements that certain actions, events or results "may," "could," "would," "might" or "will be taken," "will continue," "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein may include but are not limited to, information concerning the expectations regarding Jushi, or the ability of Jushi to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors. Many factors could cause actual future events to differ materially from the forward-looking statements in this presentation, including risks related to the ability of Jushi to successfully and/or timely achieve business objectives, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; and compliance with extensive government regulation, as well as other risks, uncertainties and other cautionary statements in the Company's public filings with the applicable securities regulatory authorities on the SEC's website at www.sec.gov and on SEDAR at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated, or expected. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward- looking information and forward-looking statements contained in this presentation are made as of the date of this presentation, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice. Operational Results Advisory Any statements regarding the Company's estimated operations following Q3 2023 do not present all information necessary for an understanding of the Company's current or future results of operations and undue reliance should not be placed on such estimates, all of which are "forward-looking information" and "forward-looking statements" subject to the risks and uncertainties described above. 2#32024 Priorities MARGIN GROWTH, DISCIPLINED COST MANAGEMENT & EFFICIENCY OPTIMIZATION Grower-Processors Retail Financials ● ● ● ● ● ● ● Optimizing balance sheet Preserving cash Decreasing and managing operating expenses Continuing margin growth expansion Attaining sustained profitability and cash flow generation ● ● Full production output Increasing plant yields, potency, turns, and improved genetics Reducing production costs Enhancing packaging and operational capabilities ● Reducing costs Increasing efficiencies and productivity Augmenting wholesale and online digital orders 3#4Wholesale Opportunities Increasing Revenues and Improving Margins * As of September 30, 2023 Growing wholesale operations ● ● ● Grew wholesale revenue over $1 million or ~19% year-over-year* Increased sell-through of Jushi-branded products at own retail network Jushi-branded product sales were ~52% of total retail revenue in Q3 2023 across our five vertical markets* Launched new product SKUs under existing product lines offering better value to customers (Sèchè Kind Grind) and new brands with premium flower offering higher margins for Jushi (Hijinks) Debuted 10 new SKUs in Q3 2023 across five brands, with ~8-10 SKUs anticipated to be introduced to consumers by year-end Introducing new products to enhance in-house product menus for expected higher percentage of Jushi-branded product sales and increased unique customer traffic 4#5Jushi's Portfolio of Assets - January 2024 NUMBER OF OPERATING STORES* Total 35 PA 17** Total 5 330k sq. ft. CULTIVATION & PROCESSING FACILITIES PA Yes 123k sq. ft. 7 VA 6 Operating Markets VA Yes 93k sq. ft. ΜΑ 2 ΜΑ Yes 50k sq. ft. 5 NV 4 NV Yes 47k sq. ft. Operating Vertical Markets * As of January 13, 2024 ** Excludes store closure in Colwyn, PA in April 2023. The Colwyn, PA store will be relocated to another location within its permit region, subject to regulatory approvals in 2024. *** Excludes one conditional license awarded in the Greater Peoria Region, IL **** Excludes one conditional license awarded in Culver City, CA, and store closures in Palm Springs, CA, and Grover Beach, CA in April 2023 and September 2023 respectively ***** As of December 31, 2023 OH 1 OH Yes 17k sq. ft. IL 4* IL ~1,203 Jushi Employees* ***** 1 CA **** CA 5#6Pennsylvania Highlights PRIMARY MARKET DRIVERS Vertically Integrated with 17* Medical Dispensaries (out of ~176(¹); ~10% of market) ~13M PA Population (2) 17* Dispensaries ~123k Sq. Ft. Facility ~942k Market Patients & Caregivers (3) (7.3% of Pop) * Colwyn store closed in April 2023 and will be relocated to another location within its permit region, subject to regulatory approvals in 2024. Scan to see more about Pennsylvania on your phone. https://jushico.com/pa-highlights ~434k Market Active Patients(4) (3.3% of Pop) 6#7Virginia Highlights PRIMARY MARKET DRIVERS Vertically Integrated with 6 Medical Dispensaries ~8.7M BEYOND/HELLO VA State Population (5) 6 Dispensaries 01 ~2.5M Health Service Area ("HSA") Il Population (6) ~93k Sq. Ft. Facility Scan to see more about Virginia on your phone. https://jushico.com/va-highlights ~49.9k Total unique patient visits from Jushi within HSA January 3, 2024(7) 7#8MA & NV Highlights SECONDARY MARKET DRIVERS MASSACHUSETTS Vertically Integrated with 2 Dispensaries 2 Dispensaries ~50k Sq. Ft. Facility Grower-processor production meeting current product demand with flexibility to expand current scale as needed NEVADA Vertically Integrated with 4 Dispensaries 4 Dispensaries ~47k Sq. Ft. Facility Grower-processor production focusing on launching several of our Jushi- branded products to achieve optimal production and high efficiency levels 8#9OH, IL & CA Highlights DEVELOPING MARKET DRIVERS Vertically Integrated with 1 Dispensary OHIO 1 Dispensaries ILLINOIS 4 Dispensaries 31 ~17k Sq. Ft. Facility Plus, conditional license awarded in the Greater Peoria Region, IL to Jushi's partner Northern Cardinal Ventures, LLC subject to regulatory approvals * Palm Springs store closed in April 2023 and Grover Beach store closed in September 2023 CALIFORNIA 1* Dispensaries 1 Flower Rooms 30 Plus, conditional license awarded in Culver City, CA subject to regulatory approvals 9#10The Jushi Retail Experience LEADING OMNICHANNEL EXPERIENCE Jushi provides patients and customers with a frictionless retail experience. NEDS Retail Design Our carefully designed and inviting cannabis experience welcomes all levels of consumers. 9:41 Hello Club Rewards Hello 200 Points Redeemable Earn instantly all 200 Points Reward $10 Off Points Reward 5. 10 8 iii. E Veteran Senior - Offers Thanks for Joining! $10 off your next purchase. Happy Birthday! 25% off your next purchase. la use GET Exp 9/18 Senior Discount 10% Off GET Exp 9/18 Veteran Discount GET 10% Off Digital Place your order online for express pickup, curbside or delivery and download our app for exclusive savings. Available in select markets. TASTEOLOGY EOLOGY SECHE SECHE am14 SECHE Products We offer our customers an expansive variety of house products across all major categories and price points. 10#11Next-Level Store Design LEADING OMNICHANNEL EXPERIENCE Beyond Hello MEDICAL MARIJUANA ● VIBE • Sleek Mid-Century Design Ample Parking • Great Signage Express Pickups Where Permitted ● VAPE 8055 Hello MEDICAL MARIJUANA GROWN IN ERAN O 3 VAPE BOSS Beganel Hello Built for Medical or Adult-use Multiple Points of Sale • UX In-Store Design Beyond TV ● 11#12Jushi's E-Commerce Platform - Our Largest Store LEADING OMNICHANNEL EXPERIENCE Industry leading digital platform facilitating online ordering, dispensary discovery and customer engagement. ~58% Order Online (Q3 23) ~20% Menu Conversion Rate (Q3 23) ~$97 Avg. Cart Size (Q3 23) 12:13 Beyond Hello beyond-hello.com - Private Locations Find your Beyond Hello Browse by state Enter location DETAILS Alexandria, VA 5902 Richmond Hwy, Alexandria, VA 22303 DETAILS PICKUP Ardmore, PA 35 Cricket Ave, Ardmore, PA 19003 Arlington, VA 500 mi SHOP MED DELIVERY 42 ✪ ✪ Scan to see our e- commerce platform https://jushico.com/e-com 12:13 Beyond Hello CANNABIS DISPENSARY Hybrid. Sour Banana Bank beyond-hello.com - Private Cache (3.5G) THC 20.40% $50.00/3.5g Add to cart 97 iva Stardawg Guaya Hybrid Spritzer Bank ★★★★ 24 Cache (3.5G) THC 23.13% $50.00/3.5g Add to cart Hybrid Tropical Banana 12#13Hello Club - Rewards App JUSHI'S LEADING OMNICHANNEL EXPERIENCE The Hello Club app provides our valued customers with a rewards program, in-app shopping and weekly app-exclusive deals. It's our most valuable retention tool. ~116k Downloads (As of 1/03/24) ~$55* Additional Monthly Spend / App User (8) *As of 1/03/24 and not including Pennsylvania and Massachusetts data 9:41 $ Hello Club Rewards Hello 200 Points Redeemable Earn instantly 200 Points Reward i 200 $10 Off 1000 Points Reward A GET IT ON Google Play Scan to download our app on your phone. https://jushico.com/thc-app 9:41 == ✔ Senior Offers Thanks for Joining! $10 off your next purchase. Happy Birthday! 25% off your next purchase. Veteran Veteran Discount 10% Off †₁ Senior Discount 10% Off Download on the App Store 1x use GET Exp 9/18 1x use GET Exp 9/18 GET GET 13#14Comprehensive Suite of Brands Across Portfolio JUSHI'S LEADING OMNICHANNEL EXPERIENCE VAPE & CONCENTRATE THE LAB THE LAB LIVE VARE SANTA THE LAB THE LAB THE FUTURS IN ALI THE LAB THE FUTURE IN ALIVE THE LAS THE LAS THE LAB SOLVENTLESS, LIVE RESIN & CURED CARTRIDGES, DISPOSABLES & CONCENTRATES BANK BTHE BANK THE BANK THE BANK FLOWER hijinks PACKAGED FLOWER & BLUNTS PACKAGED FLOWER (hijinks hinks SECHE SECHE ECHE SECHE SECHE SECHE SECHE PACKAGED FLOWER & PRE-ROLLS Scan to check out the brands now on your phone! https://jushico.com/our-brands EDIBLES & WELLNESS Nira TASTEOLOGY Niru E TEOLO 17 INFUSED CHEWS & CHOCOLATES Nira Nira+ Medicinals Nira Niru Nira Niey Nira Nira TASTEOLOGY TINCTURES & CAPSULES Nira 14#15Primary Markets Regulatory Updates Pennsylvania Governor Shapiro is considered hands-on and looking to drive policy On record several times as supporting an adult-use market (⁹) Members of both the House and Senate are in active conversations about adult-use legislation On July 6, 2023, bipartisan Senate Bill 846 was introduced by Sens. Dan Laughlin (R-49) and Sharif Street (D-3) (10) • The bill addresses the following: ● • Keeps cannabis out of the hands of anyone under 21 while giving adults 21 years and older the freedom to make responsible choices that benefit their health and wellness • Provides a fresh start to those with cannabis convictions, enabling them to expunge all non-violent marijuana convictions Allows medical cannabis operators such as Jushi to add adult-use operations to existing medical operations ● Governor Shapiro has an adult-use line item in the PA budget starting no later than 1/1/25 (¹1) New leadership within DOH continues to allow for growth in current market (12) On October 3, 2023, the House approved 280E state tax relief (13) On November 1, 2023, the House held an informational meeting to chart a path for adult-use reform (14) 15#16Primary Markets Regulatory Updates Virginia Continue to see positive progression for the Medical Cannabis Program ● • Patient Growth expected to continue in 2023 with medical clean-up bill No new licenses for medical program ● ● ● Transition from Board of Pharmacy to Cannabis Control Authority on January 1, 2024 Hemp regulation implementation Existing governor leadership continues to be a hurdle for adult-use implementation On November 7, 2023, Democrats retained a majority in the Senate (21-19) and flipped the House (51-48) (1 (15) ● • Democrats control the Virginia General Assembly First time in over 50+ years, an opposing party has flipped a chamber with a Governor from the opposing party 16#17Opportunistic Market Regulatory Updates Ohio On November 7, 2023, a voter-initiated adult-use statute passed by a 57-43 margin (16) Adult-use sales are projected to bring in over $4 billion by its fourth (17) year Ohio will become the fourth largest state with a cannabis recreational market (17) New law effective on December 7, 2023 (effective date) (18) Sales start nine months after the effective date, or Sept. 7, 2024 (¹8) Medical marijuana licenses are entitled to adult-use licenses given the following: (18) o Adult-use licenses will be issued if a medical marijuana licensee submits a complete application meeting all requirements o On or before Sept. 7, 2024, adult-use licenses will be issued to medical marijuana licensees with compliant applications Jushi License Expansion Opportunity Potentially expand to 15k sq. ft. of cultivation area o Currently 3k sq. ft. allowed under the medical marijuana tier II Cultivator License (18) • Potentially entitled to the following adult-use licenses: One Level II Cultivator License co-located with the medical marijuana tier II license cultivation facility o One Adult-Use Processor License co-located with the medical marijuana processor facility o One Adult-Use Dispensary License co-located with the medical marijuana dispensary o One Adult-Use Only Dispensary License ▪ No geographic restriction or regional limitation 17#18Appendix#19Jushi Leadership Team Jim Cacioppo CEO, Chairman & Founder Jon Barack President & Founder Michelle Mosier Chief Financial Officer J Tobi Lebowitz Chief Legal Officer & Corporate Secretary 19#20Q3 2023 - Improving Financial Performance US$ Millions, prepared under U.S. GAAP (¹) Gross Profit +$0.8 $27.7 Q3 2022 $28.5 Q3 2023 US$ Millions, prepared under U.S. Non-GAAP (¹) +$9.1 Scan to check out the latest financials now on your phone! Adjusted EBITDA $0.7 Financials and Filings :: Jushi Holdings Inc. (JUSH) (jushico.com) Q3 2022 $9.7 Q3 2023 (¹) See "Reconciliation of Non-GAAP Financial Measures" and "Reconciliation of Net Income (Loss) to Adjusted EBITDA and Adjusted EBITDA Margin" J 20#21Q3 2023 - Expanding Margin Profile US$ Millions, prepared under U.S. GAAP (1) Gross Margin +5.5 percentage points 38.1% Q3 2022 43.6% Q3 2023 Scan to check out the latest financials now on your phone! US$ Millions, prepared under U.S. Non-GAAP (1) +14.0 percentage points Financials and Filings :: Jushi Holdings Inc. (JUSH) (jushico.com) Adjusted EBITDA Margin 0.9% Q3 2022 14.9% Q3 202 (¹) See "Reconciliation of Non-GAAP Financial Measures" and "Reconciliation of Net Income (Loss) to Adjusted EBITDA and Adjusted EBITDA Margin" J 21#22Capitalization Summary (Amounts in millions) Cash(1) Total Debt(2) Net Debt Subordinate Voting Shares Outstanding Options Warrants Fully Diluted Shares Outstanding September 30, 2023 $30.5 $226.4 $195.9 September 30, 2023 196,631,598 28,374,088(3) 86,562,808(4) 311,568,494 ● ● Scan to check out the latest financials now on your phone! Financials and Filings :: Jushi Holdings Inc. (JUSH) (jushico.com) Debt Priority to reduce debt level and optimize debt terms Aggregate future total debt subject to scheduled repayments is ~$201.8(5) Capital Expenditures During the nine months ended September 30, 2023, the Company paid ~$8.4 million in capital expenditures (1) As of September 30, 2023, includes cash, cash equivalents, and restricted cash; (2) As of September 30, 2023, excluding leases and property, plant and equipment financing obligations; (3) Weighted Average Strike Price: $2.27; (4) Weighted Average Strike Price: $1.16; (5) Excludes the contractual maturities of the Company's (i) promissory notes payable to Sammartino Investments LLC and (ii) Jushi Europe SA debt, as the repayments of these two debts are contingent :22 on the resolution of the Sammartino Matter and completion of the liquidation of Jushi Europe SA, respectively.#23Adjusted EBITDA Reconciliation JUSHI HOLDINGS INC. RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA (in thousands of U.S. dollars) NET LOSS (1) Income tax expense (benefit) Interest expense, net Depreciation and amortization (2) EBITDA (Non-GAAP) Non-cash share-based compensation Inventory-related adjustments (3) Fair value changes in derivatives Indefinite-lived asset impairment Other (income) expense, net (4) Start-up costs (5) (6) Transaction costs Adjusted EBITDA (Non-GAAP) Three Months Ended September 30, 2023 $ $ (20,622) $ 8,011 9,345 5,816 2,550 1,056 7,460 (1,356) Scan to check out the latest financials on your phone! Three Months Ended June 30, 2023 9,710 $ Financials and Filings :: Jushi Holdings Inc. (JUSH) (jushico.com) Three Months (14,036) $ 8,546 9,790 6,629 10,929 2,363 (1,090) Ended September 30, 2022 418 12,620 $ (54,696) (2,802) 13,111 6,618 (37,769) 5,466 (1,197) (6,352) 37,600 1,575 118 1,212 653 (1) Net loss includes amounts attributable to non-controlling interests. (2) Includes amounts that are included in cost of goods sold and in operating expenses. (3) Includes: (i) inventory step-up on business combinations; (ii) inventory recall reserves; and (iii) reserves for discontinued products. The inventory step-up on business combinations relates to the fair value write- up on inventory acquired on the business acquisition date and then sold subsequent to the acquisition date. The inventory recall reserves relate to the estimated impact of the Pennsylvania Department of Health recall and ban of vape products containing certain cannabis concentrates. The ban was lifted in June 2022. (4) Includes: (i) remeasurement of contingent consideration related to acquisitions; (ii) losses (gains) on legal settlements; and (iii) severance costs. (5) Expansion and start-up costs incurred in order to prepare a location for its intended use. Start-up costs are expensed as incurred and are not indicative of ongoing operations of each new location. (6) Transaction costs include: (i) registration statement costs such as professional fees and other costs relating to our SEC registration; and (ii) acquisition and deal costs. 23#24Adjusted EBITDA Margin Reconciliation JUSHI HOLDINGS INC. CALCULATION OF ADJUSTED EBITDA MARGIN (in thousands of U.S. dollars) Total revenue, net Adjusted EBITDA (Non-GAAP) Adjusted EBITDA Margin (Non-GAAP) Scan to check out the latest financials on your phone! Financials and Filings :: Jushi Holdings Inc. (JUSH) (jushico.com) Three Months Ended September 30, 2023 $ $ Three Months Ended June 30, 2023 65,377 $ 9,710 $ 14.9 % 66,425 12,620 19.0 % Three Months Ended September 30, 2022 $ $ 72,817 653 0.9 % 24#25Disclaimers JUSHI HOLDINGS INC. RECONCILIATION OF NON-GAAP FINANCIAL MEASURES EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin In addition to providing financial measurements based on GAAP, the Company provides additional financial metrics that are not prepared in accordance with GAAP. The Company uses non-GAAP financial measures, in addition to GAAP financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate our financial performance. These non-GAAP financial measures are EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin (each as defined below). The Company believes that these non-GAAP financial measures reflect our ongoing business by excluding the effects of expenses that are not reflective of the operating business performance and allow for meaningful comparisons and analysis of trends in the business. These non-GAAP financial measures also facilitate comparing financial results across accounting periods and to those of peer companies. As there are no standardized methods of calculating these non-GAAP measures, the Company's method may differ from those used by others, and accordingly, the use of these measures may not be directly comparable to similar measures used by others, thus limiting their usefulness. Accordingly, these non-GAAP measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP. EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin are financial measures that are not defined under GAAP. The Company defines EBITDA as net income (loss), or "earnings", before interest, income taxes, depreciation and amortization. The Company defines Adjusted EBITDA as EBITDA before: (i) non-cash share-based compensation expense; (ii) inventory-related adjustments; (iii) fair value changes in derivatives; (iv) other (income)/expense items; (v) transaction costs; (vi) asset impairment; (vii) loss on debt extinguishment; and (viii) start-up costs. Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA by total revenue. These financial measures are metrics that have been adjusted from the GAAP net income (loss) measure in an effort to provide readers with a normalized metric in making comparisons more meaningful across the cannabis industry, as well as to remove non-recurring, irregular and one-time items that may otherwise distort the GAAP net income measure. Other companies in the industry may calculate this measure differently, limiting their usefulness as comparative measures. 25#26Disclaimers NO OFFERS This presentation does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of securities of the Company in any jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. THIRD PARTY INFORMATION This presentation may include market and industry data which was obtained from various publicly available sources and other sources believed by the Company to be true. Although the Company believes it to be reliable, the Company has not independently verified any of the data from third-party sources referred to in this presentation or analyzed or verified the underlying reports relied upon or referred to by such sources, or ascertained the underlying assumptions relied upon by such sources. The Company does not make any representation as to the accuracy of such information. REGULATORY Potential investors are aware that the cannabis market is highly regulated, and that various permits and authorizations are necessary for the import, distribution, sale or other business activities related to medicinal cannabis. The respective regulations can be subject to change, which might affect the permits required. This presentation does not intend to advertise the products of the Company. Any reference to the products serves only the information of potential investors and shall not incite the purchase of the products. COPYRIGHT All brands and trademarks mentioned in this presentation and possibly protected by third parties are subject without restriction to the provisions of the applicable trademark law and the ownership rights of the respective registered owners. The mere fact that a trademark is mentioned should not lead to the conclusion that it is not protected by the rights of third parties. The copyright for published objects created by the Company remains solely with the Company. Any duplication or use of objects such as diagrams, sounds or texts in other electronic or printed publications is not permitted without the Company's agreement. CURRENCY All references to $ or "dollar" in this presentation are references to USD, unless otherwise indicated. 26#27Endnotes ● ● ● ● ● (1) (Number of Pennsylvania dispensaries) https://www.health.pa.gov/topics/Documents/Programs/Medical%20Marijuana/MMAB%20Program%20Update%20Data-Nov%2015,%202023.pdf (2) (Population) https://www.census.gov/quickfacts/PA (3) (4) (Pennsylvania Patients & Caregivers and Active Patients) https://www.health.pa.gov/topics/Documents/Programs/Medical%20Marijuana/MMAB%20Program%20Update%20Data%20- %20Sept%206%202023.pdf and https://www.health.pa.gov/topics/Documents/Programs/Medical%20Marijuana/MMAB%20Program%20Update%20Data-Nov%2015,%202023.pdf (5) (Virginia State Population) https://www.census.gov/quickfacts/VA (6) (Health Service Area ("HAS") Il Population) https://www.census.gov/quickfacts/alexandriacityvirginia; https://www.census.gov/quickfacts/fact/table/fairfaxcountyvirginia,fairfaxcityvirginia, arlingtoncountyvirginia,alexandriacityvirginia/PST045222; https://www.census.gov/quickfacts/fact/table/princewilliamcountyvirginia,manassascityvirginia,loudouncountyvirginia,fairfaxcountyvirginia,arlingtoncountyvirginia,alexandriacityvirginia/PSTO45222 (7) (Jushi's total number of unique patient visits in Jushi's HSA II footprint since January 3, 2024). Total number of unique individuals to visit Jushi dispensaries since the beginning of a medical program within HSA II". Virginia does not provide state level patient counts. (8) Data is sourced from Springbig which doesn't include PA and MA data app users (9) (Governor Shapiro on record for supporting an adult-use market) - https://www.abc27.com/pennsylvania/will-pennsylvania-legalize-marijuana-under-josh-shapiro/; https://www.cannabisbusinesstimes.com/news/gubernatorial-race-pennsylvania-governor-josh-shapiro-jushi-trent-woloveck/; https://www.witf.org/2022/10/14/pa-election-2022-where-doug-mastriano-josh-shapiro- stand-on-the-opioid-epidemic-medical-marijuana-and-other-health-issues/; https://www.marijuanamoment.net/pennsylvania-governors-race-exposes-marijuana-divide-between-pro-legalization-ag-and-gop-senator- who-called-reform-stupid-idea/; https://twitter.com/JoshShapiro PA/status/1507139146300723203; https://www.phillyvoice.com/pennsylvania-marijuana-legalization-shapiro-2023-recreational-bipartisan-bill/; https://www.inquirer.com/news/marijuana-laws-mastriano-shapiro-decriminalization-20221007.html; Pennsylvania Governor's Office Says Ohio Marijuana Legalization Is 'Another Reminder' Of Need To Enact Reform As Lawmakers Tout 'Momentum' - Marijuana Moment (10) (Senate Bill 846) btCheck.cfm (state.pa.us) (11) (Governor Shapiro includes cannabis in budget proposal) https://www.spotlightpa.org/news/2023/05/pa-josh-shapiro-budget-public-health-covid-black-maternal-health- cannabis/#:~:text=Democratic%20Gov.%20Josh%20Shapiro's%20budget%20proposed%20a%2020%25%20tax%20adult,dollar%20amounts%20are%20in%20millions.&text=%24188.8- ,Dates%20refer%20to%20when%20the%20fiscal%20years%20end,is%20June%20of%20each%20year. (12) (PA DOH continues to allow for growth in current market) https://www.health.pa.gov/topics/programs/Medical%20Marijuana/Pages/Medical%20Marijuana.aspx; https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2023&sind=0&body=S&type=B&bn=538 (13) (Pennsylvania House approved 280E state tax relief) Pennsylvania House Approves 280E Tax Cut For Marijuana Businesses Over GOP Objections - Marijuana Moment (14) (Pennsylvania House convened for informational meeting to chart an adult-use path) Pennsylvania House Committee Schedules Marijuana Legalization Hearing For Next Week, With Chair Considering State-Run Stores - Marijuana Moment (15) (Virginia election results) Beacon Securities Marijuana Industry Update Research Report published November 13, 2023 (16) (Ohio statue passing and % of votes) Canaccord Genuity Capital Markets Industry Update Equity Research Report published November 8, 2023 (17) (Ohio adult-use market opportunity) Ohio becomes 24th state to embrace weed legalization - POLITICO (18) (Ohio Statue 2 adult-use cannabis program details) Full-Text-of-the-Law.pdf (justlikealcohol.com) 27#28Thank You Contact [email protected]

Download to PowerPoint

Download presentation as an editable powerpoint.

Related

Fiscal 3Q Investor Presentation image

Fiscal 3Q Investor Presentation

Healthcare

FY23 Full-Year Results Presentation image

FY23 Full-Year Results Presentation

Healthcare

Healthcare Network P&L Statement and Expansion Projects image

Healthcare Network P&L Statement and Expansion Projects

Healthcare

Accreditation and Quality Assurance Overview image

Accreditation and Quality Assurance Overview

Healthcare

Investment Highlights image

Investment Highlights

Healthcare

Investor Presentation image

Investor Presentation

Healthcare

IDEAYA Biosciences Interim IDE397 Phase 1 Clinical Data and Q1 2022 Corporate Update image

IDEAYA Biosciences Interim IDE397 Phase 1 Clinical Data and Q1 2022 Corporate Update

Healthcare

BioAtla Investor Presentation Deck image

BioAtla Investor Presentation Deck

Healthcare